These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15372211)

  • 21. Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression.
    Teipel SJ; Buchert R; Thome J; Hampel H; Pahnke J
    Prog Neurobiol; 2011 Dec; 95(4):547-56. PubMed ID: 21601614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular neuroimaging in Alzheimer's disease.
    Matsuda H; Imabayashi E
    Neuroimaging Clin N Am; 2012 Feb; 22(1):57-65, viii. PubMed ID: 22284733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compounds for imaging amyloid-β deposits in an Alzheimer's brain: a patent review.
    Tu P; Fu H; Cui M
    Expert Opin Ther Pat; 2015 Apr; 25(4):413-23. PubMed ID: 25746836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid imaging as a surrogate marker in clinical trials in Alzheimer's disease.
    Scheinin NM; Scheinin M; Rinne JO
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):265-79. PubMed ID: 21532540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease.
    Calamai E; Dall'Angelo S; Koss D; Domarkas J; McCarthy TJ; Mingarelli M; Riedel G; Schweiger LF; Welch A; Platt B; Zanda M
    Chem Commun (Camb); 2013 Jan; 49(8):792-4. PubMed ID: 23235438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Morimoto Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Suhara T; Higuchi M; Yamada K; Ji B
    Neurosci Lett; 2014 Oct; 581():103-8. PubMed ID: 25172571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synthesis and characterization of [(124)I]IMPY, a thioflavin-S derivative, in transgenic mouse models of Alzheimer's disease.
    Chang KW; Chen CC; Lee SY; Shen LH; Wang HE
    Appl Radiat Isot; 2009; 67(7-8):1397-400. PubMed ID: 19307132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
    Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
    Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential for a specific neuroradiologic diagnosis of Alzheimer's disease.
    Blass JP
    J Nucl Med; 2002 Aug; 43(8):1052-3. PubMed ID: 12163631
    [No Abstract]   [Full Text] [Related]  

  • 31. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
    Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular pathology of Alzheimer's disease.
    Harrington CR
    Neuroimaging Clin N Am; 2012 Feb; 22(1):11-22, vii. PubMed ID: 22284730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease.
    Bonet-Costa V; Herranz-Pérez V; Blanco-Gandía M; Mas-Bargues C; Inglés M; Garcia-Tarraga P; Rodriguez-Arias M; Miñarro J; Borras C; Garcia-Verdugo JM; Viña J
    J Alzheimers Dis; 2016; 51(3):701-11. PubMed ID: 26890773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging beta-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerization.
    Shoghi-Jadid K; Barrio JR; Kepe V; Wu HM; Small GW; Phelps ME; Huang SC
    Nucl Med Biol; 2005 May; 32(4):337-51. PubMed ID: 15878503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
    Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
    J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain.
    Zhuang ZP; Kung MP; Hou C; Ploessl K; Kung HF
    Nucl Med Biol; 2005 Feb; 32(2):171-84. PubMed ID: 15721763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioiodinated flavones for in vivo imaging of beta-amyloid plaques in the brain.
    Ono M; Yoshida N; Ishibashi K; Haratake M; Arano Y; Mori H; Nakayama M
    J Med Chem; 2005 Nov; 48(23):7253-60. PubMed ID: 16279784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral β-Amyloid Angiopathy Is Associated with Earlier Dementia Onset in Alzheimer's Disease.
    Vidoni ED; Yeh HW; Morris JK; Newell KL; Alqahtani A; Burns NC; Burns JM; Billinger SA
    Neurodegener Dis; 2016; 16(3-4):218-24. PubMed ID: 26756746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of amyloid plaques in a mouse model of Alzheimer's disease by phase-contrast X-ray computed tomography.
    Noda-Saita K; Yoneyama A; Shitaka Y; Hirai Y; Terai K; Wu J; Takeda T; Hyodo K; Osakabe N; Yamaguchi T; Okada M
    Neuroscience; 2006; 138(4):1205-13. PubMed ID: 16460878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.